Susi Roger E. sold $70K of IRMD (indirect holdings)
Susi Roger E. (CEO, President, Chairman) sold 775 indirectly-held shares of IRADIMED CORP (IRMD) at $89.79 on 2026-06-01 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure provides a datapoint on insider behavior but does not include new operational, financial, or regulatory information.
Market read
Traders may monitor for follow-on insider buys/sells, but this specific event is unlikely to drive a durable repricing absent other catalysts.
What to watch
The filing is indirect ownership and the share count is relatively small versus typical float; without additional insider activity context, signal-to-noise is low.
Background
The article is an SEC EDGAR Form 4 insider transaction disclosure for IRMD.
Ticker impact
IRMD CEO/President/Chairman Susi Roger sold 775 shares in an open-market transaction disclosed via SEC Form 4 on 2026-06-02.
Likely limited immediate price impact; any reaction is more sentiment/flow-driven than fundamental.
The filing specifies a pre-arranged Rule 10b5-1 plan, reducing the likelihood the sale reflects new negative information.
Market effects
Minimal; this is company-specific insider transaction disclosure with no stated sector-wide catalyst.
None indicated.
None indicated.
Counterpoint
Because the sale is under a 10b5-1 plan, it may be routine liquidity management rather than a bearish signal.
Key entities
- issuerIRADIMED CORP
Subject of the SEC Form 4 insider sale disclosed in the article.
- insiderSusi Roger E.
CEO, President, Chairman, and 10% owner who sold shares under a pre-arranged 10b5-1 plan.
